Introduction
This report is the sixth annual European Society of Human Reproduction and Embryology (ESHRE) publication on European data on assisted reproduction technology (ART). The five previous, also published in Human Reproduction (ESHRE, 2001a (ESHRE, ,b, 2002 (ESHRE, , 2004 (ESHRE, , 2005 , covered treatment cycles during 1997, 1998, 1999, 2000 and 2001. Data has been collected from 25 European countries and covers ART with IVF, ICSI, frozen embryo replacements (FERs), egg donations (EDs) and preimplantation genetic diagnosis (PGD) and screening (PGS) during 2002. From Finland and Sweden the number of in vitro maturation (IVM) cycles was also available. Additionally, for 2002, data on intrauterine inseminations with husband semen (IUI-H; 16 countries) and inseminations with donor semen (IUI-D; 17 countries) were included. According to the International Committee for Monitoring ART (ICMART)-WHO definitions (World Health Organization, 2002) , IUI-H and IUI-D should not be classified as ART, but data on IUI will be included in this report.
A fifth meeting with the European IVF Monitoring (EIM) Consortium was held at the ESHRE meeting in Copenhagen June 2005 with representatives from participating countries, where the present and future reporting system were discussed. The Czech Republic and Latvia were unable to provide data for year 2002, and Austria has still not provided national data to ESHRE. Croatia and Cyprus provided data for the first time.
The consortium stressed that efforts should be made to have better coverage in the Balkan and Eastern European countries.
To that end, an ESHRE workshop will be held in Belgrade during 2006.
The consortium noted that the quality of data still differs between countries. It was noted that countries like Greece and Italy are going to establish compulsory national data collection programmes in the coming years, and Belgium and Denmark are reorganizing their national registries. Presently, data collection systems, coverage, definitions and validation are different. At the ESHRE Consortium meeting in Madrid 2003, it was decided that the EIM Consortium members should adapt to the definitions listed by the ICMART and published in the WHO report (World Health Organization, 2002) . These definitions have also been adopted by ESHRE, International Federation of Fertility Societies (IFFS) and American Society of Reproductive Medicine (ASRM) / Society of Assisted Reproductive Technology (SART) and Latin American IVF Registry. Some countries have been able to adjust the 2002 data sent to ESHRE to these definitions.
The Consortium decided to continue to present annual reports and to try to improve the quality of the reports.
Materials and methods

Data collection
The present report summarizes data from IVF treatments started during 2002. The data include treatments with IVF, ICSI, ED, FER, PGD/PGS, IVM and IUI-H and IUI-D performed from the 1 January 2002 to 31 December 2002. Follow-up data on pregnancies and deliveries are cohort data. For IUI, only pregnancies, and not deliveries, were recorded. The number of clinics reporting IUI data may differ from the number of clinics presenting data on the in vitro techniques.
As it is evident from the tables, registers from a number of countries have been unable to provide some of the data.
The reporting principle used for 2002 data is basically similar to the preceding year (ESHRE, 2001a (ESHRE, ,b, 2002 (ESHRE, , 2004 (ESHRE, , 2005 .
As the data presented here is incomplete and generated through different methods using different definitions in different countries, interpretation of the data must be done with some caution. Table I shows the number of all treatment cycles recorded in each country, the number of clinics in the country (if available) and the number of clinics reporting to the register. The cycles are subdivided in IVF, ICSI, FER, ED, IVM and PDG/PGS. In Belgium, France and Iceland, the number of aspirations was used, as the number of initiated cycles was not available. In relation to FER, the number of transfers rather that the number of thawings was used in the Netherlands. Totally, 631 clinics from 25 countries reported 324 238 cycles. Table II shows data from those 12 countries where all clinics have reported to the register. The number of cycles is related to the total population in the country and the number of infants born after ART is expressed in percentage of the total number of live-births in the country. Overall, 177 429 cycles were undertaken in a population of 193.7 million, giving a mean of 916 cycles per million. The percentage of infants born after ART ranged from 1.3 to 4.2%. Belgium  30  23  3116  5776  3009  580  346  12 827  Bulgaria  11  6  533  305  28  11  877  Croatia  7  7  1254  794  573  2621  Cyprus  8  481  509  42  1032  Denmark  20  20  6067  3563  1543  148  11 321  Finland  17  17  2661  1708  3146  743  94  8352  France  92  92  21 557  25 222  12 284  233  59 296  Germany  116  29 470  39 514  15 835  84 819  Greece  50  12  2112  2963  343  169  2  5589  Hungary  11  11  2112  4406  257  32  7  6814  Iceland  1  1  145  115  75  17  352  Ireland  5  952  567  390  3  1912  Italy  120  67  6381  8977  2431  625  534  18 948  Macedonia  1  1  138  103  0  241  Netherlands  13  13  9554  5213  1468  38  16 273  Norway  9  9  2345  1566  269  4180  Poland  17  15  881  2468  901  53  4303  Portugal  20  14  1023  1518  391  11  12  2955  Russia  40  35  5457  1918  640  581  71  8667  Slovenia  3  3  817  1353  382  24  0  2576  Spain  185  36  2630  8106  1805  2059  430  15 030  Sweden  15  15  4836  4122  2063  0  60  11 081  Switzerland  20  20  1003  2214  2178  5395  Ukraine  11  8  957  527  26  184  1694  UK  77  77  16 152  11 521  7083  2204  123  37 083  All  770  631  122 634  135 048  57 162  7677  154  1563  324 238 Size of the clinics Table III shows the size distribution of the 631 reporting clinics. The size of a clinic (or unit) is based on all cycles performed per year. The size of the clinics does not include PGD/PGS, IVM and IUI. The distribution of clinics according to the number of cycles varies considerably among the countries. For example, in Russia a third performed less than 100 cycles compared with 5% in France and 30% performed more than 1000 cycles in Germany, compared with none in several countries. To what extent these variations can play a role in the results cannot be estimated from the present report. Table IV shows the age distribution of those women treated with IVF or ICSI in various countries. Table V shows the number of embryos transferred after IVF and ICSI combined. The total number of single embryo transfers (SET) was 27 872 (13.7%), dual embryo transfers 111 695 (54.8%), triple embryo transfers 54 753 (26.9%) and four or more embryo transfers 9557 (4.7%). As indicated in the table, major differences were seen between countries. The range of triple embryo transfers was 1.5% (Finland) to 52.0% (Hungary) and the range of transfer of four or more embryos was 0.0 to 42.1%.
Results
Number of treatment cycles
Age distribution
Number of embryos transferred
A total of 1923 elective SET (eSET) was reported separately. The only major contributor with specific data was Sweden with 1587 eSET. As indicated in Table V , SET accounted for 38.7% of transfers in Finland, 30 .6% in Sweden and 25.7% in Slovenia. (Table VIII) and ED (Table IX) . Table VI shows that after IVF the 28 948 pregnancies resulted from 111 140 aspirations and 98 239 embryo transfers. Thus, the mean clinical pregnancy rate was 26.0% per aspiration and 29.5% per embryo transfer. The latter figure ranged from 23.5 to 40.5% between countries. The delivery rates per embryo transfer after IVF has not been summarized because of incomplete or absence of follow-up of pregnancies in many countries, as shown in Table X . Table VII shows that after ICSI the 35 329 pregnancies resulted from 129 967 aspirations and 120 236 transfers. Thus the mean clinical pregnancy rate was 27.2% per aspiration and 29.4% per embryo transfer. The latter figure ranged from 10.4 to 41.4%. The delivery rates per embryo transfer after ICSI has not been summarized because of incomplete or absence of follow-up of pregnancies in many countries, as shown in Table X . embryo transfer after FER was 18.4%. The latter figure ranged from 14.5 to 33.0%. The delivery rates per embryo transfer after FER has not been summarized because of incomplete or absence of follow-up of pregnancies in many countries, as shown in Table XI . summarized because of incomplete or absence of follow-up of pregnancies in many countries.
Pregnancies and deliveries after treatment
Preimplantation genetic diagnosis/screening (PGD/PGS)
PGD/PGS was recorded in nine countries: Totally it involved 1563 cycles, 1485 aspirations, 1232 embryo transfers, 380 pregnancies (30.8% per transfer) and 289 deliveries. The major contributors were Italy (534 cycles), Spain (430 cycles), Belgium (346 cycles) and the UK (123 cycles).
In vitro maturation (IVM)
IVM was recorded in two countries: Finland (94 cycles) and Sweden (60 cycles). The 154 cycles resulted in 31 (20.1%) pregnancies. Table XI shows deliveries after FER in relation to singleton, twin and triplet deliveries. It is seen that the distribution of the deliveries was: singleton 4987 (80.3%), twin 1183 (19.1%) and triplet 38 (0.6%). 
Singleton, twin, triplet and quadruplet deliveries
Risks and fetal reductions
Intrauterine inseminations
Table XIII gives data on IUI-H divided in female age groups <40 years (upper panel) and ≥40 years (lower panel). For France, no stratification for age was available, and the overall results are included in the group below 40 years of age.
In women below 40 years of age, 75 746 treatments resulted in 8771 pregnancies giving a pregnancy rate per procedure of 11.6%. In women at 40 years or above, the corresponding figures were 2759, 190 and 6.9%.
In women below 40, singleton, twin and triplet pregnancies accounted for 88.7, 10.2 and 1.1% of the pregnancies, respectively. In women above 40, the corresponding values were 90.0, 8.9 and 1.1%. Table XIV gives data on IUI-D divided in female age groups <40 years (upper panel) and ≥40 years (lower panel). For France, no stratification for age was available, and the overall results are included in the group below 40 years of age.
In women below 40 years of age, 13 444 treatments resulted in 2238 pregnancies given a pregnancy rate per insemination of 16.6%. In women at 40 years or above the corresponding figures were 1335, 89 and 6.7%. In women below 40, singleton, twin and triplet pregnancies accounted for 88.7, 9.6 and 0.6% of the pregnancies. In women above 40, the corresponding figures were 93.0, 5.8 and 1.2%.
Discussion
The present report is the sixth consecutive European report on ART data covering treatment cycles from 1997 to 2002.
In 2002, the number of countries reporting to ESHRE's EIM Consortium has increased to 25 countries, covering the whole of Western Europe with the exception of Austria who are to join later, and Luxembourg where there is no IVF clinic. In Eastern Europe, the Czech Republic and Latvia, who earlier participated, were unable to provide data from 2002.
For 2002, 13 of the participating countries had a complete coverage in their reporting system, with all clinics in the country reporting: Belgium, Croatia, Denmark, Finland, France, Hungary, Iceland, The Netherlands, Norway, Slovenia, Sweden, Switzerland and the UK. Germany, with almost 85 000 cycles in 2002, is now very close to complete coverage.
Table XIII. Intrauterine insemination with husband semen (IUI-H) in 2002
Distribution of singleton, twin and triplet gestations unknown in a proportion of pregnancies. France: all treatments are classified as being in women <40 years, because of lack of age stratification. Distribution of singleton versus multiple gestations is based on deliveries. The number of reported cycles continues to grow. In 2002, 631 clinics reported 324 238 cycles, compared with 289 690 cycles in 2001, which is an increase by 12%. During the 6-year period of EIM reporting, the number of cycles has increased from 203 893 in 1997 to the 324 238 in 2002, equivalent to an overall increase by 59%. This marked increase during the period is partly because of a better coverage in the reporting systems but is also because of a true expansion of activities.
The analysis of initiated cycles is confronted with several difficulties. In some countries, the number of initiated cycles was not reported at all and, in most of the other countries, the calculated cancellation rate was beneath 10%. This may be an underestimation. There is a real need to improve the collection of cancelled cycles in order to be able to deliver proper information on the results of ART to the patients and to really compare the countries on this variable.
Within Europe, the largest contribution come from Germany with 85 000 treatment cycles followed by France with 60 000 cycles and the UK with 37 000 reported cycles. For comparison, the ASRM/SART registry reported 115 000 cycles from the United States in 2002 (Wright et al., 2005) . In southern Europe, a number of countries have a low coverage with 36 out of 185 (Spain), 67 out of 120 (Italy) and 12 out of 50 (Greece) clinics reported to the EIM. Both Italy and Greece have decided to establish compulsory National IVF Registers, which will allow a complete coverage. The situation in Spain is more uncertain.
The availability of services remained highest in Denmark with 2178 cycles per million inhabitants. It was also high in the other Nordic countries (921-1460), Belgium (1241), the Netherlands (1008) and Slovenia (1291). The average number of treatment cycles per million inhabitants was 916 in the 13 countries with complete coverage in their reportings. The proportion of ART children to all children born was again highest in the Nordic countries (2.4-4.2%) and Slovenia (3.5%). In Belgium, the figure (2.1%) is also high, even though some underreporting of deliveries seems to be present in Belgium (Tables VI and VII ). In the UK it was 1.4% and in France 1.5%.
The proportion of ICSI versus standard IVF procedures increased from 49% in 2001 to 52%, so on average ICSI was the most frequently applied technique. However, as indicated in Table I , there are many countries where ICSI was much more prevalent than IVF.
The number of embryos transferred in IVF and ICSI cycles differed substantially between countries, also in this report, but there is a clear trend during the years towards transfers with fewer embryos. The mean number of SETs increased from 12.0% in 2001 to 13.7%, whereas the proportion of two embryo transfers increased from 51. The consistent trend towards transfer of less embryos is also reflected in the overall occurrence of multiple deliveries after IVF and ICSI. In 2000, the average multiple delivery rate was 26.9%, declining to 25.5% in 2001 and to 24.5% in 2002. During the 6-year period of EIM reporting, the most remarkable finding regarding multiples has been the reduction in triplet deliveries from 3.6% in 1997, to 2.3% in 1998, 2.3% in 1999, 1.9% in 2000, 1.5% in 2001 and 1.3% in 2002 . Still, however, huge differences exist between countries in relation to triplet rates.
Regarding the multiple delivery rates, the number of fetal reductions should also be considered. A total of 461 procedures were reported, the largest numbers being from France (126), the UK (80) and Spain (65). Without this technique, the proportion of triplet deliveries would certainly have been higher, considering that the number of reported reductions is almost as high as the number of recorded triplet deliveries (n = 553, Table X (Wright et al., 2005) .
The comparison between pregnancy rate and delivery rate shows that there seems to be a huge variation in abortion rates between countries (Tables VI-VIII) . This variation is larger that can be biologically explained and raises the question of major differences either in applying the WHO/ESHRE definitions for a clinical pregnancy or in reporting the pregnancy outcomes. This shows the work that has to be done at the international level to be able to make appropriate comparisons between countries.
Altogether, 1563 cycles with PGD/PGS was reported, compared with 882 in 2001, with 543 in 2000 and with 131 in 1999. ESHRE has more comprehensive reporting on PGD by the fifth ESHRE PGD Consortium report, which included a total of 2219 cycles in 2002. The two reporting systems are different, as the PGD Consortium base their reports on detailed data from individual clinics. A comparison indicates that the number of PGD cycles reported to the National registers only include around two-thirds of the activity (ESHRE, 2006) .
For the second year, the sixth report includes European data on treatments with IUI-H (78 505 cycles) and IUI-D (14 779 cycles). The coverage of IUI activities is probably much less comprehensive than regarding the in vitro techniques. In women below 40 years of age, the pregnancy rate was 11.6% for IUI-H and 16.6% for IUI-D. In women at 40 years or above, the corresponding figures were 6.9 and 6.7%.
After IUI-H in women below 40 years of age, twin pregnancies occurred in only 10.2% and triplet pregnancies in 1.1%. After IUI-D in women below 40, twin pregnancies occurred in 9.6% and triplet pregnancies in 0.6% of the cases. The data suggest that the twinning rates are less that half of what is found with the in vitro techniques, and that the triplets rate is similar.
To summarize, the present sixth ESHRE report on ART for Europe in 2002 shows a continuing expansion of the register regarding participating clinics, countries and the number of treatment cycles reported. The pregnancy rates after IVF and ICSI increased marginally, and less embryos were transferred. After IVF and ICSI, the twinning rates remain stable, but the triplet rates have been reduced markedly from 3.6% in 1997 to 1.3% in 2002. Elective SET still had a minimal overall impact in 2002. Multiple gestations seem to be much less frequent after IUI-H and IUI-D compared with IVF and ICSI.
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